| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |